BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25264129)

  • 21. Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates.
    Quale J; Bratu S; Gupta J; Landman D
    Antimicrob Agents Chemother; 2006 May; 50(5):1633-41. PubMed ID: 16641429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbapenem resistance in cystic fibrosis strains of Pseudomonas aeruginosa as a result of amino acid substitutions in porin OprD.
    Richardot C; Plésiat P; Fournier D; Monlezun L; Broutin I; Llanes C
    Int J Antimicrob Agents; 2015 May; 45(5):529-32. PubMed ID: 25735764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries.
    Castanheira M; Deshpande LM; Costello A; Davies TA; Jones RN
    J Antimicrob Chemother; 2014 Jul; 69(7):1804-14. PubMed ID: 24603963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efflux system overexpression and decreased OprD contribute to the carbapenem heterogeneity in Pseudomonas aeruginosa.
    Ikonomidis A; Tsakris A; Kantzanou M; Spanakis N; Maniatis AN; Pournaras S
    FEMS Microbiol Lett; 2008 Feb; 279(1):36-9. PubMed ID: 18070070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
    Riera E; Cabot G; Mulet X; García-Castillo M; del Campo R; Juan C; Cantón R; Oliver A
    J Antimicrob Chemother; 2011 Sep; 66(9):2022-7. PubMed ID: 21653605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals.
    Wang J; Zhou JY; Qu TT; Shen P; Wei ZQ; Yu YS; Li LJ
    Int J Antimicrob Agents; 2010 May; 35(5):486-91. PubMed ID: 20185276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of carbapenem-resistant but cephalosporin-susceptible
    Khalili Y; Yekani M; Goli HR; Memar MY
    Acta Microbiol Immunol Hung; 2019 Dec; 66(4):529-540. PubMed ID: 31707785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
    Llanes C; Pourcel C; Richardot C; Plésiat P; Fichant G; Cavallo JD; Mérens A;
    J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of Carbapenem Resistance in Multidrug-Resistant Clinical Isolates of Pseudomonas aeruginosa from a Croatian Hospital.
    Bubonja-Sonje M; Matovina M; Skrobonja I; Bedenic B; Abram M
    Microb Drug Resist; 2015 Jun; 21(3):261-9. PubMed ID: 25565041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interplay of OpdP Porin and Chromosomal Carbapenemases in the Determination of Carbapenem Resistance/Susceptibility in Pseudomonas aeruginosa.
    Atrissi J; Milan A; Bressan R; Lucafò M; Petix V; Busetti M; Dolzani L; Lagatolla C
    Microbiol Spectr; 2021 Oct; 9(2):e0118621. PubMed ID: 34585948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interplay between mutational and horizontally acquired resistance mechanisms and its association with carbapenem resistance amongst extensively drug-resistant Pseudomonas aeruginosa (XDR-PA).
    Shu JC; Chia JH; Siu LK; Kuo AJ; Huang SH; Su LH; Wu TL
    Int J Antimicrob Agents; 2012 Mar; 39(3):217-22. PubMed ID: 22079532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating of four main carbapenem-resistance mechanisms in high-level carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Rostami S; Farajzadeh Sheikh A; Shoja S; Farahani A; Tabatabaiefar MA; Jolodar A; Sheikhi R
    J Chin Med Assoc; 2018 Feb; 81(2):127-132. PubMed ID: 29033110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of carbapenem resistance in cephalosporin-susceptible Pseudomonas aeruginosa in China.
    Zeng ZR; Wang WP; Huang M; Shi LN; Wang Y; Shao HF
    Diagn Microbiol Infect Dis; 2014 Mar; 78(3):268-70. PubMed ID: 24359931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of carbapenem resistance mechanisms in Pseudomonas aeruginosa isolates among hospitalised children in Poland: Characterisation of two novel insertion sequences disrupting the oprD gene.
    Wołkowicz T; Patzer JA; Kamińska W; Gierczyński R; Dzierżanowska D
    J Glob Antimicrob Resist; 2016 Dec; 7():119-125. PubMed ID: 27750158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inactivation of the oprD porin gene by a novel insertion sequence ISPa195 associated with large deletion in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.
    Bocharova Y; Savinova T; Shagin DA; Shelenkov AA; Mayanskiy NA; Chebotar IV
    J Glob Antimicrob Resist; 2019 Jun; 17():309-311. PubMed ID: 30684654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbapenem resistance in clinical isolates of Pseudomonas aeruginosa.
    Walsh F; Amyes SG
    J Chemother; 2007 Aug; 19(4):376-81. PubMed ID: 17855180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of outer membrane porin protein, an imipenem influx channel, in Pseudomonas aeruginosa clinical isolates.
    Naenna P; Noisumdaeng P; Pongpech P; Tribuddharat C
    Southeast Asian J Trop Med Public Health; 2010 May; 41(3):614-24. PubMed ID: 20578550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence, mechanisms, and risk factors of carbapenem resistance in bloodstream isolates of Pseudomonas aeruginosa.
    Tam VH; Chang KT; LaRocco MT; Schilling AN; McCauley SK; Poole K; Garey KW
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):309-14. PubMed ID: 17617302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations of porin, pumps, and penicillin-binding proteins in carbapenem resistant clinical isolates of Pseudomonas aeruginosa.
    Giske CG; Buarø L; Sundsfjord A; Wretlind B
    Microb Drug Resist; 2008 Mar; 14(1):23-30. PubMed ID: 18321207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of carbapenem resistance mechanism in clinical isolates of Pseudomonas aeruginosa isolated from burn patients, in Tehran, Iran.
    Mirsalehian A; Kalantar-Neyestanaki D; Taherikalani M; Jabalameli F; Emaneini M
    J Epidemiol Glob Health; 2017 Sep; 7(3):155-159. PubMed ID: 28756823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.